<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Canadian Pharmacy Blog &#187; breast cancer</title>
	<atom:link href="http://www.canadiannetmall.com/blog/tag/breast-cancer/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.canadiannetmall.com/blog</link>
	<description></description>
	<lastBuildDate>Sat, 07 May 2011 13:51:31 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.1.2</generator>
		<item>
		<title>Turning Up the Heat On Breast Cancer Chemotherapy</title>
		<link>http://www.canadiannetmall.com/blog/turning-up-the-heat-on-breast-cancer-chemotherapy/</link>
		<comments>http://www.canadiannetmall.com/blog/turning-up-the-heat-on-breast-cancer-chemotherapy/#comments</comments>
		<pubDate>Fri, 15 Apr 2011 13:50:58 +0000</pubDate>
		<dc:creator>Donald</dc:creator>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[breast cancer]]></category>
		<category><![CDATA[Chemotherapy]]></category>

		<guid isPermaLink="false">http://www.canadiannetmall.com/blog/?p=4700</guid>
		<description><![CDATA[A new breast cancer treatment uses an unusual method of administering chemotherapy— patients soak their breasts in hot water, which forces the chemotherapy drugs that are encapsulated in liposomes to release most of their contents into the breast tissue. The liposomal packaging melts above the usual body temperature (in this study, 104° F). The encapsulation [...]]]></description>
		<wfw:commentRss>http://www.canadiannetmall.com/blog/turning-up-the-heat-on-breast-cancer-chemotherapy/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Study Finds Inadequate Treatment of Early-Stage Breast Cancer</title>
		<link>http://www.canadiannetmall.com/blog/study-finds-inadequate-treatment-of-early-stage-breast-cancer/</link>
		<comments>http://www.canadiannetmall.com/blog/study-finds-inadequate-treatment-of-early-stage-breast-cancer/#comments</comments>
		<pubDate>Fri, 25 Feb 2011 07:15:34 +0000</pubDate>
		<dc:creator>Donald</dc:creator>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[breast cancer]]></category>
		<category><![CDATA[Inadequate Treatment]]></category>

		<guid isPermaLink="false">http://www.canadiannetmall.com/blog/?p=4404</guid>
		<description><![CDATA[Data from a new study point to an alarming pattern in breast cancer treatment: more than 50% of women with early-stage breast cancer have not received their full, recommended dose of potentially life-saving chemotherapy. A comprehensive retrospective analysis showed that 56% of the almost 20,800 women who were being treated for cancer in 1,243 community-based [...]]]></description>
		<wfw:commentRss>http://www.canadiannetmall.com/blog/study-finds-inadequate-treatment-of-early-stage-breast-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Aspirin and Breast Cancer Risk</title>
		<link>http://www.canadiannetmall.com/blog/aspirin-and-breast-cancer-risk/</link>
		<comments>http://www.canadiannetmall.com/blog/aspirin-and-breast-cancer-risk/#comments</comments>
		<pubDate>Wed, 12 Jan 2011 14:58:15 +0000</pubDate>
		<dc:creator>Donald</dc:creator>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Aspirin]]></category>
		<category><![CDATA[breast cancer]]></category>

		<guid isPermaLink="false">http://www.canadiannetmall.com/blog/?p=4296</guid>
		<description><![CDATA[Aspirin, often used to help prevent heart attacks and strokes, also appears to reduce the risk of the most common type of breast cancer— that is, tumors whose growth was fueled by estrogen or progesterone. Approximately 70% of women with breast cancer have the hormone receptor-positive type. The women who used aspirin at least four [...]]]></description>
		<wfw:commentRss>http://www.canadiannetmall.com/blog/aspirin-and-breast-cancer-risk/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>NSAIDs, Aspirin, and Breast Cancer Risk</title>
		<link>http://www.canadiannetmall.com/blog/nsaids-aspirin-and-breast-cancer-risk/</link>
		<comments>http://www.canadiannetmall.com/blog/nsaids-aspirin-and-breast-cancer-risk/#comments</comments>
		<pubDate>Mon, 11 Oct 2010 06:12:46 +0000</pubDate>
		<dc:creator>Donald</dc:creator>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[breast cancer]]></category>
		<category><![CDATA[NSAIDs]]></category>

		<guid isPermaLink="false">http://www.canadiannetmall.com/blog/?p=3860</guid>
		<description><![CDATA[A new study from the University of Southern California in Los Angeles indicates that women using the NSAID ibuprofen every day for five years or longer are 50% more likely than non-users to develop breast cancer, whereas women using aspirin every day for five years or longer are 81 percent more likely than non-users to [...]]]></description>
		<wfw:commentRss>http://www.canadiannetmall.com/blog/nsaids-aspirin-and-breast-cancer-risk/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Early Breast Cancer May Benefit from Letrozole</title>
		<link>http://www.canadiannetmall.com/blog/early-breast-cancer-may-benefit-from-letrozole/</link>
		<comments>http://www.canadiannetmall.com/blog/early-breast-cancer-may-benefit-from-letrozole/#comments</comments>
		<pubDate>Wed, 18 Aug 2010 09:42:38 +0000</pubDate>
		<dc:creator>Donald</dc:creator>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[breast cancer]]></category>
		<category><![CDATA[Letrozole]]></category>

		<guid isPermaLink="false">http://www.canadiannetmall.com/blog/?p=3647</guid>
		<description><![CDATA[Letrozole (Femara generic, Novartis), an aro-matase inhibitor, has been granted FDA approval as adjuvant therapy for patients with early hormone receptor-positive breast cancer. With the added indication, letrozole becomes the second agent in its class to gain an equal footing with tamoxifen (Medication Nolvadex, AstraZeneca) for immediate use after surgery in postmenopausal women with early [...]]]></description>
		<wfw:commentRss>http://www.canadiannetmall.com/blog/early-breast-cancer-may-benefit-from-letrozole/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Trastuzumab for Early-Stage Breast Cancer After Primary Therapy</title>
		<link>http://www.canadiannetmall.com/blog/trastuzumab-for-early-stage-breast-cancer-after-primary-therapy/</link>
		<comments>http://www.canadiannetmall.com/blog/trastuzumab-for-early-stage-breast-cancer-after-primary-therapy/#comments</comments>
		<pubDate>Tue, 29 Jun 2010 16:54:01 +0000</pubDate>
		<dc:creator>Donald</dc:creator>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[breast cancer]]></category>
		<category><![CDATA[Primary Therapy]]></category>
		<category><![CDATA[Trastuzumab]]></category>

		<guid isPermaLink="false">http://www.canadiannetmall.com/blog/?p=3487</guid>
		<description><![CDATA[The FDA has expanded the approved use of trastuzumab (Herceptin, Genen-tech), a biological cancer drug. In combination with other cancer drugs, tras-tuzumab is indicated for patients with HER2-positive breast cancer after surgery. Herceptin is a targeted therapy against the HER2 protein on cancer cells. An excessive amount of HER2 protein causes cancer cells to grow [...]]]></description>
		<wfw:commentRss>http://www.canadiannetmall.com/blog/trastuzumab-for-early-stage-breast-cancer-after-primary-therapy/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Ixabepilone (Ixempra) For Advanced Breast Cancer</title>
		<link>http://www.canadiannetmall.com/blog/ixabepilone-ixempra-for-advanced-breast-cancer/</link>
		<comments>http://www.canadiannetmall.com/blog/ixabepilone-ixempra-for-advanced-breast-cancer/#comments</comments>
		<pubDate>Wed, 10 Feb 2010 18:03:16 +0000</pubDate>
		<dc:creator>Donald</dc:creator>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[breast cancer]]></category>
		<category><![CDATA[Ixabepilone]]></category>
		<category><![CDATA[Ixempra]]></category>

		<guid isPermaLink="false">http://www.canadiannetmall.com/blog/?p=2991</guid>
		<description><![CDATA[Patients with advanced breast cancer drug that has not responded to other anti-cancer drugs may soon have a new treatment option. Ixabepilone (Ixempra, Bristol-Myers Squibb) has been approved for use in combination with another cancer agent, capecitabine (generic Xeloda, Roche), in patients who no longer benefit from treatment with an anthracycline (such as doxorubicin [Adriamycin, [...]]]></description>
		<wfw:commentRss>http://www.canadiannetmall.com/blog/ixabepilone-ixempra-for-advanced-breast-cancer/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

